ADEPEND

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, United Kingdom

Active ingredients

The drug ADEPEND contains one active pharmaceutical ingredient (API):

1 Naltrexone UNII Z6375YW9SF - NALTREXONE HYDROCHLORIDE

Naltrexone is an orally used, long acting specific opioid antagonist. Naltrexone binds competitively to receptors which are located in the central and peripheral nervous system and hence blocks the access for exogenously administered opioids. Read about Naltrexone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADEPEND Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07BB04	Naltrexone	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BB Drugs used in alcohol dependence
Discover more medicines within N07BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1501478, 1501489, 1501490
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 204142
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-653697303
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1057429, 1057430, 1063026
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100236596